Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 21, 2022HemaSphereOpen Access

Predicting Individual Changes in Terminal Half-Life After Switching to Extended Half-Life Concentrates in Patients With Severe Hemophilia

View Full Paper
Ask AI
Bookmark
Share

Authors

OVOlav VerslootEIEmma IsermanPCPierre Chelle

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Versloot et al. (2022) studied this question.

synapsesocial.com/papers/6aa01b323ffc717e97be87f1https://doi.org/10.1097/hs9.0000000000000694
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Barriers to compliance with prophylaxis therapy in haemophilia2001 · 161 citations
  2. 2The Half-life of Infused Factor VIII Is Shorter in Hemophiliac Patients with Blood Group 0 than in those with Blood Group A2000 · 117 citations
  3. 3Implementation strategies: recommendations for specifying and reporting2013 · 2,859 citations
  4. 4Terminal half‐life of FVIII and FIX according to age, blood group and concentrate type: Data from the WAPPS database2021 · 28 citations
  5. 5Limited blood sampling for pharmacokinetic dose tailoring of FVIII in the prophylactic treatment of haemophilia A2010 · 115 citations